Johnson & Johnson Consumer Companies Inc is featuring is Cytomimic technology in five scientific posters accepted by and exhibited at the 22nd Annual Meeting of the World Congress of Dermatology in Seoul, Korea.

This proprietary technology comes from decades of research to harness the power of bioelectricity to improve skin rejuvenation. Based on ground-breaking science that delivers significant results in antiaging, Cyctomimic has demonstrated anti-inflammatory activity, collagen and elastin production, as well as clinically proven safety and effectiveness in reducing the signs of photoaging, accordind to a press release from the company.

“We are proud to showcase this advanced technology at such a prominent international assembly,” says Dr Ying Sun, a Distinguished Research Fellow and Science Leader at Johnson & Johnson. “This technology is first-of-its-kind and we believe strongly in showcasing its efficacy and building its awareness among the international dermatology community.” 

The five posters showcase clinical studies that demonstrate improvement of the skin’s appearance starting within minutes of application with continued improvements over time.

[Source: Johnson & Johnson]